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Previous genetic and biochemical experiments have shown that the vaccinia virus J3 protein has three different roles in
mRNA synthesis and modification. First, J3 is a (nucleoside-2-O-)methyltransferase which methylates the 2 position of the
first transcribed nucleotide, thus converting a cap-0 to a cap-1 structure at the 5 ends of mRNAs. Second, J3 is a processivity
factor for the virus coded poly(A) polymerase. Third, J3 has recently been shown to have intermediate and late gene positive
transcription elongation factor activity in vivo. Previous experiments have shown that the poly(A) polymerase stimulatory
activity and the (nucleoside-2-O-)methyltransferase activity are two independent functions of the protein that can be
genetically separated through site-directed mutagenesis. In this article, the relationship between the J3-mediated transcrip-
tion elongation activity and the two other functions of the protein was investigated by constructing several site-directed
mutant viruses that contain specific defects in either methyltransferase or poly(A) polymerase processivity functions. The
results demonstrate that the J3 positive transcription elongation factor activity is a third independent function of the protein
that is genetically separable from its two other functions in mRNA modification. The results also show that neither the poly(A)
polymerase stimulatory nor the methyltransferase activities of the J3 protein is essential for virus growth in cell culture.INTRODUCTION
Vaccinia, the prototypic orthopoxvirus, has a 192-kb
double-stranded DNA genome which encodes approxi-
mately 200 genes and replicates strictly in the cytoplasm
of host cells. Due to the location of its replication cycle,
vaccinia must encode its own multi-subunit RNA poly-
merase and transcription factors that are necessary for
carrying out distinct early, intermediate, and late stages
of gene expression (Moss, 2001). Thus, vaccinia has
served as a good model for studying the fundamental
mechanisms that regulate transcription.
Intermediate and late (together termed “postreplica-
tive”) vaccinia gene transcription is distinct from the
transcription of vaccinia early genes specifically with
respect to the process of termination. Early gene tran-
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4scription termination occurs in response to a cis-acting
termination signal that is recognized as the mRNA se-
quence U5NU (Yuen and Moss, 1987; Shuman and Moss,
1988). Upon transcribing this signal, the polymerase ter-
minates 30–50 nucleotides downstream in a manner that
is dependent upon three virus coded factors: the het-
erodimeric capping enzyme (VTF) (Shuman et al., 1987),
a DNA-dependent ATPase (NPH-I) (Christen et al., 1998;
Deng and Shuman, 1998), and the early gene-specific
RNA polymerase subunit H4 (Mohamed and Niles, 2000).
As a result of this termination mechanism, early gene
transcripts are characteristically homogeneous in length.
In contrast, a polymerase that transcribes an intermedi-
ate or late gene reads through U5NU early termination
sequences and terminates in a seemingly random fash-
ion to produce a population of transcripts that is very
heterogeneous in length (Mahr and Roberts, 1984). To
date, no cis-acting termination signal has been identified
for postreplicative genes and if one exists, it must be
both inefficient and degenerate in sequence. However,
previous genetic and biochemical experiments have
shown that the vaccinia gene products A18, G2, and J3
influence postreplicative gene transcription elongation© 2002 Elsevier Science (USA)
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(Black and Condit, 1996; Xiang et al., 1998, 2000; Latner
et al., 2000; Lackner and Condit, 2000).
It was recently shown using an in vitro transcription
assay that the 56-kDa A18 protein is a transcript release
factor required for dissociation of nascent RNA from a
ternary transcription elongation complex (Lackner and
Condit, 2000). In addition, it has been previously shown
that A18 is a DNA-dependent ATPase and a 3-5 DNA
helicase (Bayliss and Condit, 1995; Simpson and Condit,
1995). Consistent with these in vitro biochemical proper-
ties, viruses with mutations in A18 produce abnormally
long transcripts in vivo that, when transcribed from op-
posing promoters, can hybridize to one another and form
excessive amounts of double-stranded RNA. This pro-
cess induces the cellular 2–5A pathway, leading ulti-
mately to RNase L-catalyzed RNA degradation and abor-
tion of the infection (Pacha and Condit, 1985; Bayliss and
Condit, 1993; Xiang et al., 1998; Lackner and Condit,
2000).
Mutations in the G2 and J3 genes have been identified
by two independent genetic selections (Condit et al.,
1996; Latner et al., 2000). First, mutations in both genes
have been discovered as extragenic suppressors of a
temperature-sensitive mutation in the A18 transcript re-
lease factor. Second, mutations in both genes have been
identified from a selection for viruses that are dependent
for growth on the transcription elongation enhancing
drug isatin--thiosemicarbazone (IBT). Although the
mechanism of action of IBT is unknown, treatment of an
infection with IBT has the same effect as mutations in
A18, that is, IBT causes the production of excessively
long transcripts leading to dsRNA formation and abortion
of the infection (Pacha and Condit, 1985; Bayliss and
Condit, 1993). In direct contrast to A18 mutants, viruses
containing IBT-dependent mutations in either the G2 or
the J3 gene produce postreplicative gene transcripts that
are shorter than normal and that are specifically trun-
cated from the 3 end. As a result of these defects in
transcription, G2 and J3 mutants produce reduced quan-
tities of large proteins at late times during infection
(Black and Condit, 1996; Xiang et al., 2000). The suppres-
sion of both G2 and J3 mutants by A18 and their depen-
dence on IBT for growth make sense: both mutation of
A18 and treatment with IBT enhance transcription elon-
gation, thus compensating for the truncation of tran-
scripts resulting from mutation of G2 or J3. In summary
the in vivo genetic evidence suggests that G2 and J3
have similar roles as positive transcription elongation
factors for intermediate and late genes.
Although the G2 protein has no previously described
function and shares no significant sequence homology
to any known proteins with the exception of other pox-
virus homologues, the J3 protein has two previously
described mRNA modification activities. First, J3 is a
(nucleoside-2-O-)methyltransferase that converts a
cap-0 to a cap-1 structure at the 5 end of mRNAs by
using S-adenosylmethionine to methylate the 2 position
of the first transcribed nucleotide (Barbosa and Moss,
1978a,b; Schnierle et al., 1992). Methylation at the 2
position on the penultimate nucleotide of transcripts is a
common modification of higher eukaryotic mRNA, al-
though its purpose remains a mystery (Wei and Moss,
1975). Second, J3 is the processivity factor subunit of the
heterodimeric viral poly(A) polymerase (Gershon et al.,
1991; Gershon and Moss, 1993). The large catalytic sub-
unit of the poly(A) polymerase, E1, will by itself rapidly
catalyze the addition of approximately 35 A residues on
the 3 end of mRNA at a rate of about 120 residues per
minute in vitro. After the poly(A) tail grows to about 35
bases in length, E1 abruptly ceases rapid elongation of
the tail, then very slowly continues to add A residues at
a rate of 0.25–1 per minute (Gershon and Moss, 1992;
Schnierle et al., 1992). Upon addition of J3 to the in vitro
reaction, E1 returns to a rapid processive mode of elon-
gation until the total length of the poly(A) tail reaches
about 200 nucleotides (Gershon and Moss, 1993). Thus,
in addition to its activity as a positive transcription elon-
gation factor for postreplicative genes, J3 is involved in
modifying both the 5 and the 3 ends of mRNAs.
Published site-directed mutagenesis experiments
have shown that the (nucleoside-2-O-)methyltransferase
and E1 stimulatory activities are two independent func-
tions of J3 that are genetically separable (Gershon et al.,
1998). More specifically, these experiments have shown
that certain mutations in the J3 protein can precisely
abrogate either the (nucleoside-2-O-)methyltransferase
activity or the E1 stimulatory activity as measured in vitro
with mutant J3 proteins that have been overexpressed
and purified from bacteria (Schnierle et al., 1994; Shi et
al., 1997). These experiments in combination with the
more recent observation that J3 is a positive transcription
elongation factor (Latner et al., 2000; Xiang et al., 2000)
have invited the following question: Is the J3 positive
transcription elongation factor activity somehow func-
tionally linked to one or both of its two other RNA mod-
ifying activities, or is the role of J3 as a transcription
factor a third independent function of the protein? An in
vitro assay to measure the transcription stimulatory ac-
tivity of J3 does not currently exist. Therefore, an answer
to this question required the construction and in vivo
characterization of several viruses which contain site-
directed mutations that have been shown in vitro to
specifically disrupt either E1 poly(A) polymerase stimu-
latory activity or (nucleotide-2-O-)methyltransferase ac-
tivity (Schnierle et al., 1994; Shi et al., 1996, 1997). The
results described below demonstrate that J3 mediated
transcription elongation activity is a third, independent,
genetically separable activity of the protein that is other-
wise not related to either of the two other RNA-modifying
activities. In addition, several viruses were constructed
that contain previously described charge-to-alanine
scanning mutations located at or near the surface of the
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protein in an attempt to determine which regions of J3
are important for mediating its effects on postreplicative
gene transcription. Three of the J3 charge-to-alanine
scanning mutants are resistant to IBT, preliminarily sug-
gesting a surface area of the protein that may be impor-
tant for mediating the effects of J3 on transcription.
RESULTS
Construction of site-directed J3 mutants
To test the hypothesis that the J3 positive transcription
elongation factor activity is a third independent activity of
the protein, eight J3 site-directed mutant viruses were
constructed by transient dominant selection as de-
scribed under Materials and Methods (Falkner and
Moss, 1990; Hassett and Condit, 1994; Hassett et al.,
1997). The specific J3 mutations that were inserted into
the viruses are listed in Table 1. Seven of the eight
mutant alleles that were inserted into the virus have
been previously described by in vitro experiments
(Schnierle et al., 1994; Shi et al., 1997). The remaining
previously undescribed allele is called K175R. The eight
J3 mutant viruses fall into two groups. The first group
consists of two viruses, K175R and CF3c, that contain
point mutations which cause the purified recombinant J3
mutant proteins to be specifically defective in vitro for
either methyltransferase or poly(A) polymerase stimula-
tion activity, respectively. The K175R virus contains a
missense mutation that converts a catalytic lysine at
codon 175 in the methyltransferase active site of the J3
protein to an arginine. Purified recombinant protein con-
taining the K175R mutation lacks methyltransferase ac-
tivity but retains poly(A) stimulatory activity in vitro (data
not shown). The CF3c virus contains two missense
mutations that convert the histidine at codon 56 to an
arginine (H56R) and the isoleucine at position 58 to a
serine (I58S) (Shi et al., 1997). These mutations are lo-
cated on a surface region of the protein that is important
for interacting with the E1 poly(A) polymerase, and the
purified recombinant protein is thus specifically defective
for poly(A) tail synthesis in vitro (Shi et al., 1997). Of note,
the CF3 virus described here lacks two mutations that
were originally described in the initial characterization of
the purified recombinant protein. Specifically, the previ-
ously described recombinant CF3c protein contains two
additional missense mutations that convert cysteine 178
and cysteine 272 to serine residues and were shown not
to affect the assayable properties of the protein (Shi et
al., 1997). It was hypothesized that if J3 elongation factor
activity is a third independent function of the protein,
then viruses containing the K175R or CF3c mutations
would produce normal length transcripts even if they
maintain their methyltransferase and E1 stimulation de-
fects in vivo. Thus, the K175R and CF3c viruses serve as
two critical controls. The remaining viruses fall into a
second group which contains charge-to-alanine scan-
ning (AS) mutations (Schnierle et al., 1994) that are lo-
cated at or near the surface of the protein and were
selected for use in the current study based on the J3
crystal structure observations (Hodel et al., 1996). It has
been shown previously that the purified recombinant J3
proteins containing each of these mutations are normal
TABLE 1
Summary of J3 Site-Directed Mutants
Virus Mutationa
In vitrob In vivob
MTase E1-S MTase E1-S Elongation IBT
wt NA      S
J3x G96D      D
J3-7 fs 49; 58aa NA NA    D
CF3c H56R, I58S      S
K175R K175R      S
AS-4 R79, D80-A      S
AS-5 R97, H98, H99-A     /c R
AS-6 R107, D108-A      S
AS-8 R122, K125, K126-A     /c R
AS-9 H129, K132-A    /  S
AS-15 R220, R223-A     /c R
a fs indicates the J3-7 mutant contains a single nucleotide deletion in codon 49 that produces a frameshift truncation of the protein 58 amino acids
from the N-terminus. Each of the remaining missense mutations are indicated as the wt amino acid, location of the codon which is mutated, and the
mutant residue.
b , normal wt function; , defective or mutant function. S, IBT sensitivity; R, IBT resistance; D, IBT dependence. MTase, (nucleoside-2-
O)methyltransferase activity; E1-S, E1 poly(A) polymerase stimulatory activity. Elongation indicates length of intermediate and late gene transcripts
relative to wt.
c /, IBT-resistant mutants AS-5, AS-8, and AS-15 produce normal length transcripts in the absence of IBT-like wild-type, but they have an altered
transcription phenotype in the presence of IBT that is different from the wild-type virus. See text for details.
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for methyltransferase and E1 stimulation activities in vitro
(Schnierle et al., 1994). It was hypothesized that some of
these mutations might disrupt a region of J3 that is
important for binding to additional proteins in a transcrip-
tion elongation complex and thus produce a specific
defect in transcription elongation while maintaining nor-
mal methyltransferase and E1 stimulation activities.
Therefore, construction of these viruses could potentially
map on the surface of J3 a region that might be respon-
sible for stimulating transcription. The charge-to-alanine
scanning mutant viruses that were constructed are
called AS-4, AS-5, AS-6, AS-8, AS-9, and AS-15.
Plaque phenotypes of site-directed mutants
Previous experience with G2 and J3 mutants has
shown that the response of a virus to IBT is a good
indicator of the mRNA synthesis phenotype of the virus
(Hassett and Condit, 1994; Black and Condit, 1996; Con-
dit et al., 1996; Latner et al., 2000; Xiang et al., 2000). For
example, wild-type virus is IBT sensitive (IBTs) and
makes normal length transcripts, while IBT-dependent
(IBTd) G2 and J3 mutants make short 3 truncated tran-
scripts in the absence of drug. Interestingly, mutation of
G2 can also result in IBT resistance (IBTr). Although none
of the previously isolated G2 IBTr mutants have been
analyzed directly for their transcription elongation phe-
notype, it has been suggested that IBT resistance may
represent a phenotype intermediate between sensitivity
and dependence resulting from a partial defect in G2
elongation activity. Therefore, each of the site-directed
mutants were examined in a plaque assay for their re-
sponse to IBT. Figure 1 shows that as controls, the wt
virus is IBT sensitive, while the previously characterized
J3x and J3-7 viruses are IBT dependent. The J3x virus is
FIG. 1. Plaque phenotypes of mutant viruses. Confluent monolayers of BSC40 cells in 60-mm dishes were infected with an appropriate dilution of
virus and incubated at 37°C in the presence or absence of IBT under an agar overlay for 4 days. Dishes were stained overnight with a second neutral
red containing agar overlay. Agar was then removed and cells were stained with crystal violet. The mutant used for infection is indicated at the top
of each column. The presence or absence of IBT during the infection is indicated at the left of each row.
67VACCINIA J3 PROTEIN FUNCTIONAL DOMAINS
somewhat leaky at 37°C as attested by the presence of
very small, barely visible plaques in the absence of drug,
consistent with previously described results. J3-7, as
previously described (Latner et al., 2000), has a tight IBTd
phenotype but forms very small plaques, consistent with
the fact that it is difficult to grow to high titer. Importantly,
the CF3c and K175R viruses are both IBT-sensitive sim-
ilar to wt, suggesting that they may have normal tran-
scription phenotypes. The CF3c virus consistently pro-
duces slightly smaller-than-wt plaques, suggesting that it
may be somewhat defective for growth. The AS-4, AS-6,
and AS-9 viruses are all IBT sensitive, suggesting that
that they also have no transcription defects. Interestingly,
the AS-5, AS-8, and AS-15 viruses are all IBT resistant.
One-step growth analysis
To support the plaque phenotype data, one-step
growth analysis was performed on each mutant (Fig. 2).
By 72 h postinfection, wt virus produced approximately
77 PFU/cell, significantly higher than the T0 background,
in the absence of IBT and was inhibited for growth in the
presence of IBT. J3x produced only background levels of
progeny in the absence of IBT and approximately 0.8
PFU/cell in the presence of IBT, 5.5-fold higher than
background. This confirms that the J3x virus is IBT de-
pendent and is difficult to grow to high titer. J3-7 pro-
duced background levels of progeny in the absence of
IBT and slightly more in the presence of drug, demon-
strating that it is significantly crippled and very difficult to
grow to a high titer. AS-5 produced between 13 and 17
PFU/cell both in the presence and in the absence of IBT,
demonstrating that it is clearly resistant. AS-8 produced
6 PFU/cell in the absence of drug and 3 PFU/cell in the
presence, showing that while it is also IBT resistant, it
may be weakly inhibited by the drug. This one-step
growth phenotype for AS-8 is consistent with the fact
that, in contrast to other IBTr AS mutants, AS-8 formed
smaller plaques in the presence of IBT compared to the
absence of IBT (Fig. 1). AS-15 produced between 22 and
32 PFU/cell in the presence and absence of IBT, showing
that it is strongly IBT resistant. The CF3c virus produced
approximately 31 PFU/cell in the absence of IBT and
background levels of progeny in the presence of drug.
Thus, CF3c is IBT sensitive similar to wt, but relative to
wt may be somewhat hindered for growth. These data
are consistent with the observation that CF3c reproduc-
ibly produces slightly smaller plaques than wt (Fig. 1).
More extensive one-step growth experiments revealed
that CF3c grows more slowly than wt virus but eventu-
ally reaches a wt yield (data not shown). The K175R,
AS-4, AS-6, and AS-9 viruses all produced between 106
and 125 PFU/cell in the absence of IBT and only 0.02–
0.41 PFU/cell in the presence of IBT. Therefore, they are
all IBT sensitive and grow to wt titer. In summary, with the
FIG. 2. One-step growth analysis of J3 site-directed mutants. Confluent monolayers of BSC40 cells in 60-mm dishes were infected with the indicated
viruses at an m.o.i.  3.3. Infections were incubated in the presence or absence of IBT at 37°C and were harvested at 0 and 72 h postinfection.
Lysates were then titered under permissive conditions for each virus. Specifically, all lysates with the exception of J3x and J3-7 were titered at 37°C
in the absence of IBT. The J3x and J3-7 lysates were titered in the presence of IBT at 37°C. The numerical data presented at the left is the same data
presented in the graph. Note that virus yield in the graph is shown as PFU/cell on a logarithmic scale. Solid bars indicate lysates that were harvested
at 0 h postinfection. Striped bars represent lysates that were harvested at 72 h postinfection.
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exception of J3-7, these results support the plaque phe-
notypes shown in Fig. 1 and show that the CF3c and
K175R control viruses and three charge-to-alanine scan-
ning mutants are IBT sensitive. In addition, the one-step
growth data confirm that the AS-5, AS-8, and AS-15 vi-
ruses are all IBT resistant.
Viral protein synthesis
As an initial test of the prediction that the J3 site-
directed mutant viruses would have a transcription phe-
notype that is consistent with their responses to IBT, their
patterns of viral gene expression were examined by
metabolically labeling proteins in infected cells with
[35S]methionine at various times postinfection. The total
infected cell protein was then analyzed by SDS–PAGE
and autoradiography (Fig. 3). The results show that the
protein synthesis profile of each virus can be placed into
one of three different phenotypic categories that directly
correlate with the responses to IBT. Shown in Fig. 3 are
autoradiograms that are representative examples of
each phenotype. The first phenotypic category is com-
posed of the IBT-sensitive viruses and is illustrated by
the wt and K175R viruses. In the absence of IBT, the wt
virus shuts off host protein synthesis between 3 and 6 h
postinfection, early viral protein synthesis begins be-
tween 0 and 3 h and subsequently decays, and synthesis
of intermediate and late virus proteins begins between 3
and 6 h and is maintained throughout the remainder of
the infection. In the presence of IBT, wt early protein
synthesis and shutoff is normal, late protein synthesis
begins on schedule, but all protein synthesis decays by
9 h postinfection. This observation is consistent with
previously published results (Cooper et al., 1979; Pacha
and Condit, 1985; Black and Condit, 1996) and is largely
attributed to induction of the 2-5A RNA degradation path-
way in IBT-treated wt infections (Cohrs et al., 1989; Pacha
et al., 1990; Meis and Condit, 1991). All of the IBT-sensi-
tive viruses, which include CF3c, K175R, AS-4, AS-6, and
AS-9, show a protein synthesis profile that is indistin-
guishable from wt virus.
The second phenotypic category is composed of the
IBT-dependent viruses and is represented by J3x. When
the J3x mutant is grown in the absence of IBT, it displays
normal shutoff of host protein synthesis by 6 h postin-
fection and has normal early protein synthesis that de-
cays between 3 and 6 h postinfection (Xiang et al., 2000).
Beginning at 6 h and maintained throughout infection, J3x
produces normal amounts of small intermediate and late
proteins, but produces reduced quantities of large inter-
mediate and late proteins. As previously described, this
specific defect in protein synthesis is due to the fact that
the J3x postreplicative transcripts are 3 truncated and
are too short to encode full-length large proteins (Xiang
et al., 2000). In the presence of IBT, J3x shows normal
shutoff of host protein synthesis, early protein synthesis
begins and decays normally, and equivalent amounts of
both large and small proteins are produced at late times
during infection, showing that the defect in J3x transcrip-
tion is corrected by the addition of drug. Thus, the profile
of J3x protein synthesis in the presence of IBT is com-
FIG. 3. Protein synthesis in wt and mutant-infected cells. Confluent monolayers of BSC40 cells in 35-mm dishes were infected at m.o.i.  10 with
all viruses except for J3-7, which was infected at an m.o.i.  6.6 due stock titer constraints. Infected cells were incubated at 37°C in the presence
or absence of IBT for 0, 3, 6, 9, 12, or 24 h postinfection at which time they were pulse labeled for 15 min with [35S]methionine. Infected cells were
then lysed in SDS–PAGE sample buffer and solubilized proteins were analyzed by SDS–PAGE. The gels were stained with Coomassie blue, dried,
and autoradiographed. The migration of molecular size standards is shown in kilodaltons. The time postinfection (in hours) at which each sample was
harvested and whether IBT was present is indicated at the top of the gels.
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parable to the wt profile in the absence of IBT in terms of
the kinetics of synthesis and the size and quantity of
proteins produced.
The third phenotypic category is composed of the
IBT-resistant viruses AS-5, AS-8, and AS-15 and is rep-
resented in Fig. 3 by AS-5. Both in the presence and in
the absence of IBT, the pattern of AS-5 protein synthesis
appears identical to the pattern of protein synthesis
demonstrated by the wt virus growing in the absence of
drug. Thus regardless of IBT treatment, AS-5 has normal
shutoff of host synthesis, normal early protein synthesis
and shut-off, and normal intermediate and late protein
synthesis that persists throughout infection.
Viral mRNA synthesis
A crucial step in determining if the J3 transcription
elongation factor activity is linked to the other two func-
tions of the protein was to examine the mRNAs synthe-
sized by each site-directed mutant. Thus mRNAs pro-
duced by each virus were examined by Northern blot
analysis. Briefly, total RNA was harvested from infected
cells at various times postinfection, electrophoresed on
formaldehyde agarose gels, transferred to nylon mem-
branes, and hybridized with standard early (gene C11),
intermediate (gene G8), and late (gene F17) gene ribo-
probes. Figure 4A shows RNA harvested at 3 h postin-
fection and probed with an early gene riboprobe. As
previously described (Xiang et al., 2000), the early wt
transcripts are characteristically homogeneous in length
due to sequence-specific transcription termination. Im-
portantly, all of the site-directed mutant viruses produce
early transcripts that are similar in length to those pro-
duced by wt, indicting they have no dramatic defects
early in mRNA synthesis. When the infections are per-
formed in the presence of IBT (Fig. 4B), the early tran-
scripts still appear normal in all cases, indicating that IBT
has no gross effect on early transcription. Close inspec-
tion of the data in Figs. 4A and 4B suggests that the early
transcripts produced in infections by J3-7 and CF3c may
be slightly shorter than transcripts produced by the other
viruses. This small decrease in size would be consistent
with a decreased poly(A) tail length (see below) and
indicates that in both of these mutants the poly(A) stim-
ulation activity is defective in the context of the virus core
where early transcription occurs.
When RNA harvested at 9 h postinfection from cells
infected in the absence of IBT is probed with the inter-
mediate gene riboprobe (Fig. 4C), a characteristic heter-
ogeneous population of transcripts is detected in all
cases. Consistent with previous results, the wt virus
produces a normal distribution of intermediate tran-
scripts and the IBT-dependent mutants, J3x and J3-7,
produce a population of transcripts that is on average
shorter than those produced by the wt virus. Importantly,
the CF3c and K175R viruses both produce intermediate
transcripts that are of wt length, indicating that they do
not have a defect in intermediate gene transcription. The
remaining IBT-sensitive viruses, AS-4, AS-6, and AS-9,
also produce intermediate transcripts that are of a nor-
mal length. Interestingly, the intermediate transcripts
produced by the IBT-resistant mutants AS-5, AS-8, and
AS-15 are similar to the transcripts produced by wt and
the other IBT-sensitive viruses.
When RNA harvested at 9 h postinfection from cells
infected in the presence of IBT is probed with the inter-
mediate gene riboprobe, some interesting results are
obtained (Fig. 4D). In the presence of IBT, wt virus pro-
duces smaller-than-normal intermediate RNAs, consis-
tent with RNA degradation, as described previously
(Pacha and Condit, 1985; Bayliss and Condit, 1993). The
same smaller-than-normal distribution is observed from
each IBT-sensitive virus sample, including CF3c, K175R,
AS-4, AS-6, and AS-9, demonstrating that they, similar to
wt, experience RNA degradation in the presence of IBT.
For all of these IBTs viruses, IBT treatment also caused
rRNA degradation, revealed by ethidium bromide stain-
ing of gels prior to transfer (data not shown). In contrast,
in the presence of IBT the IBT-dependent viruses J3x and
J3-7 both produce transcripts that are longer than RNAs
produced in the absence of drug, resembling the tran-
scripts produced from the wt virus in the absence of IBT,
between 1.4 and 7 kb in length. This suggests that IBT is
compensating for the elongation defects that these IBTd
viruses have in transcription. Interestingly, in the pres-
ence of IBT, the IBT-resistant viruses AS-5, AS-8, and
AS-15 all appear to produce intermediate transcripts that
are of similar length to those of the IBT-dependent vi-
ruses J3x and J3-7.
Figure 4E shows RNA harvested at 12 h postinfection
and probed with a late gene riboprobe. Once again, wt
virus produces a normal heterogeneous distribution of
transcripts with a strong homogeneous band of 1.4 kb in
length that is consistent with previous observations. In
the absence of drug, the J3x and J3-7 IBT-dependent
viruses produce transcripts that are, on average, shorter
than those produced by the wt virus. The remaining
IBT-sensitive and IBT-resistant viruses produce tran-
scripts in the absence of drug that are similar to the wt
transcripts. Figure 4F shows RNA harvested at 12 h
postinfection from cells infected in the presence of IBT
and probed with a late gene probe. By 12 h postinfection,
it appears that wt and the other IBT-sensitive viruses
have reduced production of late transcripts relative to the
amount of transcripts produced in the absence of IBT.
This observation is probably a result of the degradation
of intermediate transcripts, which encode late transcrip-
tion factors. The J3x and J3-7 IBTd viruses produce late
transcripts that, similar to intermediate transcripts pro-
duced in the presence of drug, are slightly longer than
the transcripts produced in the absence of drug. This
once again suggests that IBT is compensating for the
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transcription defects in these viruses, allowing them to
synthesize normal length transcripts. The IBT-resistant
viruses AS-5, AS-8, and AS-15, unlike the sensitive vi-
ruses, produce late transcripts in the presence of drug.
In addition, these transcripts produced in the presence
of drug are essentially of the same length as those
produced in the absence of drug.
In vivo poly(A) polymerase stimulatory activity
After determining that the CF3c and K175R viruses are
wt for RNA synthesis, the next step in determining if the
J3 transcription elongation activity is linked to the other
two RNA modifying functions was to examine each of the
viruses for in vivo poly(A) polymerase stimulatory activity.
FIG. 4. Northern analysis of RNA from wt and mutant infected cells. Confluent monolayers of BSC40 cells in 100-mm dishes were infected at an
m.o.i.  10 with each virus except for J3-7, which was infected at an m.o.i.  6 due to stock titer constraints. Infected cells were incubated at 37°C
in the presence or absence of IBT for 3, 9, or 12 h postinfection; then total cellular RNA was purified. RNAs (1.5 g each) were electrophoresed on
formaldehyde agarose gels and were transferred to nylon. The 3, 9, and 12 h RNAs, respectively, were probed with standard early (gene C11),
intermediate (gene G8), or late (gene F17) radiolabeled riboprobes. The autoradiograms are shown as follows: A: 3 h RNA, early C11 probe, -IBT; B:
3 h RNA, early C11 riboprobe, IBT; C: 9 h RNA, intermediate G8 probe, -IBT; D: 9 h RNA, intermediate G8 probe, IBT; E: 12 h RNA, late F17 probe,
-IBT; F: 12 h RNA, late F17 probe, IBT. The migration of molecular weight markers are shown at the left of each panel in kilobase pairs.
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Briefly, cells were infected with each virus in the absence
of IBT and total RNA was harvested at 12 h postinfection.
The RNAs were then labeled at the 3 end with [32P]pCp
(cytidine 3, 5-bisphosphate) by T4 RNA ligase and were
digested with RNases A and T1. The RNase-resistant
labeled poly(A) tails were then analyzed on a denaturing
polyacrylamide gel and the autoradiogram is shown in
Fig. 5. In addition, the autoradiogram shown in Fig. 5 was
quantified on a Phosphorimager and a graphical distri-
bution of the poly(A) tails synthesized by each virus is
shown in Fig. 6. Previous experiments have shown that
the poly(A) tails present at 12 h postinfection are essen-
tially all viral in origin and do not represent host mRNA
poly(A) tails (Xiang et al., 2000). Consistent with previous
results (Xiang et al., 2000), the wt virus synthesizes
poly(A) tails up to 150 nucleotides in length, with a peak
in distribution between 60 and 100 nucleotides in length.
The J3x, K175R, AS-4, AS-5, AS-6, AS-8, and AS-15 viruses
all synthesize poly(A) tails that are similar to those pro-
duced by the wt virus, indicating that they have normal
poly(A) polymerase stimulatory activity. In contrast, the
J3-7 IBTd null mutant is defective for poly(A) tail synthe-
sis, as previously described (Xiang et al., 2000). Most of
the poly(A) tails synthesized by J3-7 are less than 50
nucleotides in length, which is consistent with this virus
lacking the poly(A) polymerase stimulatory function. The
distribution of poly(A) tails in a CF3c infection is repro-
ducibly indistinguishable from a J3-7 infection and clearly
distinguishable from wt virus and other mutant virus
infections. This result shows that the CF3c virus, similar
to J3-7, is also defective for poly(A) tail synthesis in vivo,
consistent with previously described in vitro results (Shi
et al., 1997). There also appears to be a reduction in the
overall abundance of poly(A) tails synthesized by both
J3-7 and CF3c relative to the other viruses; however, the
reasons for the difference in abundance is not clear. The
apparent reduction in the amount of poly(A) tails pro-
duced by both viruses could be attributable either to a
generalized inefficiency in poly(A) tail synthesis by each
virus in vivo or to technical difficulties in recovering small
poly(A) tails in the labeling procedure. Importantly how-
ever, CF3c clearly is defective for poly(A) tail synthesis
both in vitro and in vivo but otherwise retains a normal
transcription phenotype. Interestingly, the AS-9 virus con-
sistently appeared to have a very slight defect in E1
stimulatory function also, with most of the tails being less
than 100 bases in length as detected in several indepen-
dent experiments. However, the slight defect in AS-9 is
difficult to visualize from the experiment shown in Fig. 5.
In vivo 2-O-methyltransferase activity
The final step in determining if the J3 transcription
elongation activity is linked to the other two J3 functions
was to examine the in vivo 2-O-methyltransferase activ-
ity of each virus. Briefly, BSC40 cells were infected with
each virus, incubated at 37°C for 10 h, and then labeled
FIG. 5. Analysis of poly(A) tail lengths in wt and mutant viruses.
Confluent monolayers of BSC40 cells in 60-mm dishes were infected at
an m.o.i.  10 with each virus except for J3-7, which was infected at an
m.o.i.  6.6 due to titer constraints. Infected cells were incubated at
37°C for 12 h; then total cellular RNA was harvested. One microgram of
total RNA was then 3 end labeled with 5 Ci of [32P]pCp (3000
Ci/mmol), digested with RNases A and T1, and the labeled; RNase-
resistant poly(A) tails were electrophoresed on a 10% polyacrylamide 8
M urea sequencing gel. The gel was dried and subjected to autora-
diography. The migration of size markers, in nucleotides, is shown at
left.
FIG. 6. Distribution of poly(A) tail lengths in wt, J3-7, and CF3c samples. The distribution of poly(A) tails from the wt, J3-7, and CF3c samples
analyzed on the gel shown in Fig. 5 was further examined by Phosphorimager analysis. The relative amounts of poly(A) tails for each sample are
plotted as a function of the distance they traveled from the top of the gel. The x-axis indicates distance from the top of the gel in arbitrary units, and
all graphs, including the ladder (top left), are plotted on the same scale. The y-axis indicates relative amounts of radioactivity in arbitrary units.
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with [32P]orthophosphoric acid for 2 h. Poly(A)-RNA was
then purified and digested with RNases A, T1, T2, and calf
intestinal alkaline phosphatase. The dinucleotide cap
structures on the 5 ends of mRNAs are resistant to
ribonucleolytic digestion due to the 5-5 nature of the
linkage between the 7-methyl G residue and the first
transcribed nucleotide. If the first transcribed nucleotide
is methylated at the 2 position, the phosphodiester bond
between the first and second transcribed nucleotides is
also protected from ribonucleolytic cleavage. After diges-
tion, an mRNA is thus degraded to nucleosides, phos-
phates, and either a dinucleotide or a trinucleotide that
represents the cap-0 or cap-1 structure, respectively. The
digestion products were electrophoresed on a 20% de-
naturing polyacrylamide gel which was dried and sub-
jected to Phosphorimager analysis (Fig. 7). The results
show that wt viral transcripts have a cap-1 structure as
predicted. In contrast, both the J3-7 null mutant and the
K175R virus, which contains a point mutation in the
methyltransferase catalytic site, produce transcripts that
have cap-0 structures, demonstrating that both viruses
lack the J3 2-O-methyltransferase activity in vivo. Inter-
estingly, the J3xmutant transcripts have a cap-1 structure
in vivo. This result was surprising because the purified
recombinant J3x protein has been shown to be defective
for 2-O-methyltransferase activity in an in vitro assay
(Xiang et al., 2000). The remaining viruses, CF3c, AS-4,
AS-5, AS-6, AS-8, AS-9, and AS-15 all produce cap-1 in
vivo.
DISCUSSION
In light of the fact that the vaccinia virus J3 protein has
two previously characterized biochemically independent
roles in modifying both the 5 and the 3 ends of mRNA
(Gershon, 1998), the recent realization that J3 also has a
positive transcription elongation factor activity raised the
following question: Is the J3 transcription factor activity
related to the two other mRNA modification activities or
is it a third independent function of the protein? To
directly address this question, several site-directed J3
mutant viruses were constructed in an attempt to create
viruses that are specifically defective for each of the
three J3 functions. Rather than simply assaying the pre-
viously described recombinant-purified mutant proteins,
actual viruses containing the site-directed mutations
were constructed because an in vitro assay for the J3
transcription elongation factor activity does not currently
exist. Eight site-directed J3 mutant viruses were con-
structed by transient dominant selection. Two of the
viruses, called K175R and CF3c, contained mutations
that were known to disrupt either the methyltransferase
or the poly(A) polymerase stimulatory functions, respec-
tively (as assayed in vitro) (Shi et al., 1997). The six
remaining viruses contained charge-to-alanine scanning
(AS) mutations in which the target side chains were
known from the crystal structure to be located at or near
the solvent-accessible surface of the J3 protein (Hodel
et al., 1996). These mutants were constructed in attempt
to create viruses that are specifically defective for
transcription elongation and thus map onto the surface
of J3 an elongation domain. The resulting mutant viruses
were biochemically assayed in vivo for the three J3 ac-
tivities. The location of each J3 mutation and the results
of the biochemical characterization are summarized in
Table 1.
The results provide several lines of evidence showing
that the J3 transcription elongation factor activity is a
third independent function of the protein that is not re-
lated to the 2-O-methyltransferase or E1 poly(A) poly-
merase stimulatory activities. First, based on Northern
analysis and supported by the protein synthesis profiles,
IBT response, and plaque phenotypes, it appears that
the CF3c and K175R viruses have a normal transcription
phenotype throughout infection that is indistinguishable
from the wt virus. It was also shown that the CF3c virus
is specifically defective for in vivo poly(A) tail synthesis
and the K175R virus is specifically defective for in vivo
2-O-methyltransferase activity. Thus, the sole defect in
CF3c is for E1 poly(A) polymerase stimulation and the
sole defect in K175R is for 2-O-methyltransferase activ-
ity. Second, it was shown that the only defect in the J3x
point mutant is for transcription elongation activity. Al-
though previous evidence has demonstrated that the
recombinant-purified J3x protein does not have 2-O-
methyltransferase activity in vitro, the 2-O-methyltrans-
FIG. 7. In vivo 2-O-methyltransferase assay. Confluent monolayers of
BSC40 cells in 100-mm dishes were infected at an m.o.i. 10 with each
virus except for J3-7, which was infected at an m.o.i.  6 due to titer
constraints. Infections were incubated at 37°C for 10 h; then the
infected cells were washed with 6 ml of phosphate-free, serum-free 1
DME. [32P]orthophosphoric acid (3.33 mCi) diluted in 4 ml of phosphate-
free, serum-free 1 DME was applied to the cells which were then
incubated at 37°C for two additional hours. Poly(A)-RNA was har-
vested from the infected, labeled cells at 12 h postinfection. The RNA
was then digested with RNases A, T1, T2, and calf intestinal alkaline
phosphatase. The digestion products were then electrophoresed on a
20% polyacrylamide 8 M urea sequencing gel. The gel was then dried
and subjected to Phosphorimager analysis.
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ferase activity is clearly present in vivo. (Differences
between in vivo and in vitro phenotype are not uncom-
mon and are probably attributable to the vast differences
in assay environment. For example, a temperature-sen-
sitive mutant in the vaccinia mRNA capping enzyme is
apparently normal for mRNA capping in vivo and defec-
tive in vitro (Hassett et al., 1997).) Therefore, three differ-
ent viruses, CF3c, K175R, and J3x, each contain a dif-
ferent defect in one of the three known J3 functions and
together demonstrate that the positive transcription elon-
gation activity of J3 is a third independent function of the
protein that can be genetically separated from the other
two activities.
The results presented here also demonstrate that long
poly(A) tails are not essential for vaccinia virus growth in
cell culture. Experiments in yeast and metazoan cells
demonstrate that the process of polyadenylation is cou-
pled to several other processes including transcription
initiation, transcription termination, mRNA capping, and
mRNA splicing, and that poly(A) tails themselves play
roles in initiation of translation, mRNA stability, and ex-
port of mRNA from the nucleus (Minvielle-Sebastia and
Keller, 1999; Wahle and Ruegsegger, 1999; Proudfoot,
2000). Consistent with the coupling of transcription and
mRNA processing in the eukaryotic host, the evolution of
mRNA capping, transcription elongation, and polyadenyl-
ation functions within a single protein molecule, the J3
gene product, suggests that these could be concerted
reactions in vaccinia. Nevertheless, our results show
that the poly(A) polymerase stimulatory function of the J3
protein is not strongly coupled to any other facet of
mRNA synthesis, processing, or function, since the pro-
files of RNA and protein synthesis are identical in wt and
CF3c-infected cells. Similarly, our results show that a
mutation that decreases the poly(A) tail length from 100–
150 to 30–50 nt in length does not have a dramatic effect
on mRNA stability or translation in the vaccinia system.
(Nuclear export and splicing are irrelevant to vaccinia
mRNA metabolism.) While the absolute requirement for
poly(A) tails would probably require study of a mutant in
the E1 catalytic subunit of the viral poly(A) polymerase,
our results show that in cell culture, the poly(A) polymer-
ase stimulatory function of the viral poly(A) polymerase
behaves similar to an accessory function, not absolutely
required for normal mRNA metabolism and function.
Additionally, the results presented here demonstrate
that cap-1 structures are also not essential for virus
growth in tissue culture. The 5 ends of mRNAs synthe-
sized by most lower eukaryotes and plants contain
mainly cap-0, while most higher eukaryotes and their
viruses produce mRNAs with cap-0 and cap-1 structures
(Banerjee, 1980; Schnierle et al., 1992). Although the
importance of the terminal m7G in the stability and trans-
lation of mRNA has been well documented (Mitchell and
Tollervey, 2001; Pestova et al., 2001), the normal role of
additional cap ribose methylation remains unknown. To
date, 2-O-methylated caps are only known to be re-
quired for synthesis of influenza virus transcripts (Plotch
et al., 1981). Thus, it is perhaps not surprising that 2-O-
methylation of vaccinia transcripts appears to be dis-
pensable.
Some information about the solvent-exposed surface
area of the J3 protein that may be important for mediating
its effects on transcription can be gleaned by mapping
the mutated residues in the IBTr charge-to-alanine scan-
ning mutants and the IBTd mutant J3x on the published J3
protein crystal structure (Fig. 8). The residues highlighted
in green in Fig. 8 indicate the charge-to-alanine scanning
mutations that are present in the IBT-resistant viruses
AS-5, AS-8, and AS-15. It was initially hypothesized that
the resistant mutants would have a transcription pheno-
type intermediate between that of wt and IBTd virus.
Specifically IBTr viruses would produce transcripts in the
absence of IBT that were only slightly 3 truncated. The
slight truncation would be insufficient to affect protein
synthesis but sufficient to compensate for the overstimu-
lation of transcription elongation normally induced by
IBT, hence the IBT resistance phenotype. The Northern
blot analysis presented here does not reveal any obvious
differences in transcript length comparing IBTr and IBTs
viruses; however, it is possible that the hypothesized
elongation defect in IBTr mutants is too subtle to be
detected by this analysis. The most likely alternative
explanation for the IBTr phenotype would be that IBT
exerts its action by binding to the J3 protein, and the IBTr
J3 mutations abrogate IBT binding. However, the facts
that null mutation of either genes J3 or G2 yield an IBTd
phenotype (Meis and Condit, 1991; Latner et al., 2000),
that some mutations of G2 yield an IBTr phenotype (Has-
sett and Condit, 1994), and that one additional IBTr mu-
tation maps to the second largest subunit of the viral
RNA polymerase (Condit et al., 1991) all argue against J3
being the binding target for IBT. We favor the interpreta-
tion that the primary target of IBT is neither J3 nor G2 but
some other protein, perhaps the RNA polymerase, and
that mutation of J3 or G2 can modulate elongation in a
fashion which compensates for the elongation stimula-
tion normally caused by IBT. Thus we believe that an
intermediate elongation defect still seems the most plau-
sible explanation for the IBTr phenotype of the J3 mu-
tants. In this context, the J3 surface region affected by the
IBTr mutants, shaded green and best visualized in the
bottom view of Fig. 8, could represent the outline of an
“elongation domain” of the J3 protein. Mechanistically, the
elongation domain may represent a surface that inter-
acts with other transcription factors or RNA polymerase
in an elongation complex. The elongation domain would
also include the glycine residue at codon 96 (highlighted
in purple in Fig. 8) that is mutated to an aspartate (G96D)
in the J3x IBT-dependent point-mutant. The wild-type
glycine is close to the surface of the molecule and
normally provides a kink in the alpha carbon backbone
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between two charged residues, aspartate 95 and argi-
nine 97. Replacement of glycine 96 with a charged resi-
due may significantly alter the local surface charge and
structure of the protein such that, by analogy with the
IBT-resistant mutants, its ability to bind additional tran-
scription factors may be compromised.
When mutated, the residues in Fig. 8 that are high-
lighted in black have no effect on transcription elonga-
tion. Interestingly, however, the residues indicated by the
circle in the “back” view are the mutations in the CF3c
virus and they have provided additional information
about the mechanism by which J3 influences transcrip-
tion. Specifically, the mutations in CF3c have been
shown to inhibit the interaction between J3 and E1 in
vitro. Noting that the CF3c virus has a normal transcrip-
tion phenotype and retains its defect in E1 stimulation in
vivo, it is likely that heterodimer formation between J3
and E1 is not required for J3-mediated transcription elon-
gation activity. Furthermore, E1 probably does not medi-
ate any hypothetical contacts between J3 and the tran-
scription apparatus.
Although the role of J3 in stimulating postreplicative
gene transcription elongation is a third independent
function of the protein that can be genetically separated
from its 2-O-methyltransferase and E1 poly(A) polymer-
ase stimulatory activities, the mechanism by which it
stimulates transcription remains unclear. Typically, eu-
karyotic or bacterial transcription factors that regulate
postinitiation events fall into one of two broad categories:
(1) those that enhance the rate of elongation or (2) those
that induce or inhibit termination. Currently, there is not
enough information to distinguish whether J3 is acting at
FIG. 8. J3 crystal structure. The published J3 crystal structure [Protein Data Bank (PDB) identification number 1V39 is available through the National
Center for Biotechnology Information at http://www.ncbi.nlm.nih.gov and is shown as a space-filling model]. The panels are labeled according to their
rotational relationship to “front” view. Specifically, the right, left, bottom, and top views are rotated 90° relative to the front view. The back view is rotated
180° relative to the front. The arrow indicates the methyltransferase active site. S-adenosylhomocysteine, the product of the reaction between
S-adenosylmethionine (SAM) and the 2 position of the ribose on the penultimate nucleotide, and 7-methyl G-triphosphate are to the left and right of
the arrow, respectively. The residue highlighted in purple is glycine 96, which is mutated to aspartate in the IBT-dependent J3x point mutant. The
residues highlighted in green are the residues that are mutated to alanine in the IBT-resistant mutants (AS-5, AS-8, and AS-15). The residues
highlighted in black are those that have no effect on transcription when mutated to alanine (mutants AS-4, AS-6, and AS-8). The circle in the back
view indicates the residues that are mutated in the CF3c poly(A) polymerase stimulatory mutant. These residues are important for binding to the
poly(A) polymerase. The arrow points to the K175R residue (in black) that is disrupts methyltransferase activity by inhibiting SAM binding.
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the elongation or termination stage. The transcription
defects observed in the J3 null or IBT-dependent mutants
could be explained if the normal function of J3 is to
stimulate the rate of elongation or to suppress pausing
either through modification of the polymerase structure
or by stimulating the intrinsic transcript cleavage activity
of the polymerase. Alternatively, J3 could prevent termi-
nation through direct interaction with release factors
such as A18, as supported by preliminary evidence
which suggests that J3 directly binds to A18 in a pull-
down experiment in vitro (E. Niles, personal communica-
tion). It is also possible that J3, similar to the pol II
elongation factors ELL and CSB, may stimulate the rate
of elongation through an alternate mechanism that has
not yet been defined (Conaway et al., 2000). Finally, it is
also conceivable that J3 does not have a direct role in
either elongation or termination, but rather simply con-
tributes to the overall stability of the transcription com-
plex while binding to perform its 2-O-methyltransferase
and poly(A) polymerase stimulatory functions. Establish-
ing the precise mechanism by which J3 enhances tran-
scription will probably require an in vitro assay to mea-
sure its activity at each stage of transcript synthesis.
MATERIALS AND METHODS
Cell culture, plaque assay, and one-step growth
The conditions for culturing BSC40 African green mon-
key kidney cells and methods for vaccinia virus cultiva-
tion, infection, plaque assay, and one-step growth have
been previously described (Condit and Motyczka, 1981;
Condit et al., 1983). The wild-type vaccinia strain WR and
the IBT-dependent mutants J3-7 and J3x have been pre-
viously described (Condit and Motyczka, 1981; Latner et
al., 2000; Xiang et al., 2000). IBT was prepared fresh
before each use and applied at a final concentration of
45 M as previously described (Pacha and Condit, 1985).
Plasmids and transient dominant selection
The pGEX/KG plasmids used to express the CF3c,
AS-4, AS-5, AS-6, AS-8, AS-9, and AS-15 mutant copies of
the J3 protein for in vitro experiments have been previ-
ously described (Schnierle et al., 1994; Shi et al., 1997).
The K175R missense mutation, constructed in exactly the
same fashion as the AS mutations, results in the ex-
change of a lysine for an arginine at codon 175 of the J3
open reading frame. To prepare the pGEX/KG plasmids
for transient dominant selection, the EcoRI fragment from
pBSgpt4, which contains the vaccinia 7.5K promoter driv-
ing expression of the Escherichia coli gpt cassette (Has-
sett et al., 1997), was cloned into the EcoRI site of the
pGEX/KG plasmids. The sequences of the mutant J3
genes on the recombinant plasmids were verified by
sequence analysis prior to transfection.
The method for performing transient dominant selec-
tion has been previously described (Falkner and Moss,
1990; Guan and Dixon, 1991; Hassett and Condit, 1994).
Briefly, a 60-mm dish of CV-1 cells was pretreated with
mycophenolic acid (MPA), infected at a multiplicity of
infection (m.o.i.)  0.5 with wild-type vaccinia virus
(strain WR), transfected with 2 g of plasmid DNA and 30
l of lipofectin (Life Technologies), and incubated at
37°C until the cytopathic effect was complete. Infected
cell lysates were harvested and titered on CV-1 cells
pretreated for 12 h with MPA, xanthine, and hypoxanthine
and on CV-1 cells growing in the absence of drugs.
Plaques were stained with nutrient agar containing
0.005% neutral red 4 days postinfection (Condit et al.,
1983). Plaques growing in the presence of MPA were
picked and titered in the presence and absence of 45
M IBT at 31, 37, and 40°C. The MPA-resistant plaques
that were isolated from cells transfected with the plas-
mids containing the AS-4, AS-6, AS-9, K175R, and CF3c
alleles were all sensitive to IBT and grew at all three
temperatures. The MPA-resistant plaques that were iso-
lated from cells transfected with the plasmids containing
the AS-5, AS-8, and AS-15 alleles were able to grow in
both the presence and the absence of IBT at all three
temperatures. AS-4, AS-6, AS-9, K175R, and CF3c can-
didate mutant plaques that grew at 37°C in the absence
of IBT were picked and grown under the same conditions
from which they originated. AS-5, AS-8, and AS-15 can-
didate mutant plaques that grew at 37°C in the presence
of IBT were picked and grown under the same conditions
from which they originated. The mutations inserted into
each virus generated various altered restriction sites
within the J3 sequence. Thus, the mutant candidates
were screened for the J3 mutations by RFLP analysis of
PCR fragments. Candidate J3 mutant viruses were then
plaque purified and the entire J3 gene coding region was
sequenced from each virus to confirm the presence of
the mutations.
Protein pulse-labeling
Pulse-labeling of proteins in virus infected cells was
performed as previously described (Condit and Mo-
tyczka, 1981). Briefly, confluent 35-mm dishes of BSC40
cells were infected with wt or mutant virus at a high
m.o.i. in the absence or presence of 45 M IBT and
incubated at 37°C as indicated in the figure legends.
At various times postinfection, cells were metaboli-
cally labeled with 10 Ci [35S]methionine (1175 Ci/
mmol) for 15 min. Cells were lysed on the dishes by
addition of SDS–polyacrylamide gel electrophoresis
(PAGE) sample buffer, and solubilized proteins were
analyzed by SDS–PAGE on 8% gels. The gels were
stained with Coomassie blue, dried, and autoradio-
graphed.
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Isolation of total cellular RNA
Dishes (100 mm) of confluent BSC40 cells were in-
fected with wt or mutant virus at a high m.o.i. in the
absence or presence of 45 M IBT at 37°C as indicated
in the figure legend. At various times after infection, total
cellular RNA was purified using RNeasy Total RNA puri-
fication columns essentially as described by the manu-
facturer (Qiagen, Inc., Chatsworth, CA) except that the
infected cell lysates from each 100-mm dish were ap-
plied to two RNeasy columns and the total RNA was
eluted in a total volume of 200 l of RNase-free water.
Northern analysis
Northern analysis was performed essentially as pre-
viously described (Xiang et al., 2000) with the following
exceptions: 1.5 g of purified total RNA from infected
cells was adjusted to a final concentration of 0.4 
MOPS buffer (1 MOPS buffer  20 mM MOPS, 8 mM
sodium acetate, 1 mM EDTA, pH 7.0), 1.8 M formalde-
hyde, and 40% formamide in a final volume of 24.5 l.
The samples were heated to 65°C for 15 min and then
chilled on ice. One microliter of 1 mg/ml ethidium bro-
mide and 2 l of RNA loading buffer (50% glycerol, 1 mM
EDTA, 0.0 5% bromphenol blue, 0.0 5% xylene cyanole)
were added to each sample prior to loading on the gel.
The samples were electrophoresed at 80 V through 1.2%
agarose gels containing a final concentration of 1 
MOPS buffer and 2.2 M formaldehyde in an electrophore-
sis buffer containing 1  MOPS. Riboprobes were syn-
thesized, hybridized, and washed from the blots as pre-
viously described and as described in the Promega Pro-
tocols and Applications Guide.
In vivo poly(A) tail length measurements
Poly(A) tail lengths were measured using a protocol
modified from Minvielle-Sebastia et al. (1998). Total RNA
(1.5 g) harvested from cells at 12 h postinfection was
labeled in a 30 l reaction containing 50 mM HEPES pH
7.5, 5 M ATP, 10 mM MgCl2, 3.3 mM DTT, 10% DMSO,
300 g/ml BSA, 20 Ci 3-5[5-32P]pCp (3000 Ci/mmol),
and 20 units of T4 RNA ligase (NEB). Reactions were
incubated on ice for 18 h and then were digested at 37°C
for 4.5 h by the addition of 50 l of a digest mix contain-
ing 40 g tRNA, 100 U RNase T1, 10 g RNase A, 10 mM
Tris–HCl pH 7.5, and 300 mM NaCl. Twenty microliters of
a mixture containing 2 mg/ml proteinase K, 130 mM
EDTA, and 2.5% SDS was added and the reactions were
incubated at 37°C for an additional 30 min. Reactions
were then extracted with an equal volume of phenol:
chloroform:isoamyl alcohol (25:24:1). The aqueous layer
was precipitated by the addition of 60 g glycogen and
3 vol of 100% ethanol followed by centrifugation for 30
min at 16,100 RCF. Pellets were resuspended in 10 l of
a solution containing 95% formamide, 20 mM EDTA, 0.1%
bromphenol blue, and 0.1% xylene cyanole. Five microli-
ters of each sample was electrophoresed on 8% poly-
acrylamide 8 M urea sequencing gels in 1 TBE at 1700
V, 72 mA, and 35 W with constant power. Gels were fixed
in 10% methanol and 10% acetic acid and then were dried
and subjected to autoradiography.
Cap marker synthesis
Poly(A) RNA was synthesized essentially as previously
described (Shuman and Moss, 1990) in a 100 l reaction
containing 8 g M13 single-stranded DNA, 50 mM Tris–
HCl pH 7.8, 2.5 mM DTT, 3 mMMnCl2, 1.5 mM ATP, 20 M
cordycepin triphosphate, 10 Ci 32P-ATP (3000 Ci/
mmol), 10 u E. coli RNA polymerase (USB), and 40 u
RNasein (Promega). The reaction was incubated at 37°C
for 20 h; then poly(A) RNA was purified by batchwise
oligo(dT) selection. Briefly, the reaction was made 50 mM
with respect to EDTA and then was incubated at 70°C for
10 min. The reaction was combined with an equal vol-
ume of 2 binding buffer [1 M NaCl, 20 mM Tris–HCl pH
7.8, 2 mM EDTA, 1% SDS] and was incubated with 10 mg
of oligo(dT) cellulose (NEB) for 30 min. The cellulose-
bound poly(A) RNA was pelleted by centrifugation (1 min
at 6000 RCF) and then was washed three times with 1
binding buffer. Poly(A) RNA was eluted twice with 600 l
of elution buffer [10 mM Tris–HCl pH 7.8, 1 mM EDTA,
0.2% SDS] and was precipitated with 300 mM sodium
acetate, 40 g glycogen, and an equal volume of isopro-
panol. The poly(A) RNA 5 ends were converted to the
cap-0 structure essentially as previously described (Shu-
man and Moss, 1990) in a 15 l reaction containing [50
mM Tris–HCl pH 7.8, 6 mM KCl, 1.2 mM MgCl2, 20 Ci
32P-GTP, 10 pmol poly(A) RNA substrate, 150 nM vac-
cinia virus capping enzyme (generously provided by Ed
Niles), 1 mM S-adenosylmethionine, 40 u RNasein (Pro-
mega)]. For conversion to cap-1, 280 ng wild-type vac-
cinia virus J3 protein, purified as previously described
(Xiang et al., 2000), was included in the reaction. Capping
reactions were incubated for 19 h at 37°C. Capped
poly(A) was once again selected over oligo(dT) cellulose
and precipitated as described above. The cap-labeled
RNA was digested in a reaction containing 10 mM Tris–
HCl pH 7.8, 50 mM sodium acetate, 2 mM EDTA, 1 g
RNase A (Sigma), 100 u RNase T1 (Boehringer Mann-
heim), 25 u RNase T2 (BRL), and 1 u calf alkaline phos-
phatase (BRL).
In vivo cap labeling
One 100-mm dish of BSC40 cells was infected at an
m.o.i.  10 with each virus (except J3-7 which was at
m.o.i.  4.8 due to titer constraints). Infected cells were
incubated with 1 DME (BRL) and 10% fetal calf serum at
37°C for 10 h. The medium was removed and the in-
fected cells were washed with 4 ml of phosphate-free,
serum-free 1 DME. Cells were then incubated in the
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presence of 3.33 mCi of [32P]orthophosphoric acid
(285.5Ci/mg) diluted in 4 ml of phosphate-free 1 DME
for 2 h at 37°C. Cells were washed with 4 ml PBS and
then total RNA was extracted with an RNeasy kit (Qia-
gen) according to the manufacturer’s instructions except
that approximately 107 cells were lysed with 1.2 ml of RLT
buffer 1% -mercaptoethanol, and the lysate was spun
over two separate RNeasy columns. The total RNA from
each 100-mm dish of infected cells was eluted in a total
volume of 200 l water and made 50 mM with respect to
EDTA. Samples were heated to 70°C for 5 min and then
poly(A) RNA was selected over 10 mg oligo(dT) resin as
described above.
Cap analysis
Analysis of labeled caps was adapted from a proce-
dure described by Kuge et al. (1998). Isopropanol-precip-
itated RNA, labeled either in vitro or in vivo, was resus-
pended in 10 l of digestion mix containing 10 mM
Tris–HCl pH 7.8, 50 mM sodium acetate, 2 mM EDTA, 1
g RNase A (Sigma), 100 u RNase T1 (Boehringer Mann-
heim), 25 u RNase T2 (BRL), and 1 u calf alkaline phos-
phatase (BRL) and incubated for 19 h at 37°C. To dilute
the cap markers while normalizing the salt concentra-
tions relative to in vivo samples, approximately 5000
Cherenkov cpm of RNase treated, in vitro labeled RNA
was added to another 10 l of digestion mix before
further processing. Digested samples were then concen-
trated to approximately 1 l in a speed vacuum and then
resuspended in 10 l of [95% formamide, 20 mM EDTA,
0.1% bromphenol blue, 0.1% xylene cyanole]. Samples
were electrophoresed on a 20% polyacrylamide, 8 M
urea sequencing gel in 1 TBE at 1700 V, 72 mA, 33 W
with constant power. The excess free-labeled phosphate
from this analysis was distributed between the bottom of
the gel and the lower buffer reservoir. The gel was fixed
briefly in a solution of 20% methanol and 20% acetic acid,
dried, and then subjected to Phosphorimager analysis.
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